Article

Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals

2024-03-22

Abstract excerpt

<title>Abstract</title> <p>Fecal calprotectin is an established marker of gut inflammation in inflammatory bowel disease (IBD). Elevated levels of fecal calprotectin as well as gut microbial dysbiosis have also been observed in other clinical conditions. However, systemic and multi-omics alterations linked to elevated fecal calprotectin in older individuals remain unclear. This study comprehensively investigated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 73c7b3af-5f29-5a95-9fde-aceeea90c787
DOI: 10.21203/rs.3.rs-4045749/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individualsDOI 10.21203/rs.3.rs-4045749/v1Read

Multi-omics phenotyping characterizes molecular divergence underlying different clinical scenarios of inflammatory bowel diseaseSemantic proximity Read

Fecal calprotectin: beyond intestinal organic diseases.Semantic proximity Read

Deciphering the microbiome–metabolome landscape of an inflammatory bowel disease inception cohortSemantic proximity Read

Generally-healthy individuals with aberrant bowel movement frequencies show enrichment for microbially-derived blood metabolites associated with reduced kidney functionSemantic proximity Read

Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohortsSemantic proximity Read

Ultra-Processed Foods, Gut Microbiota, and Inflammatory Bowel Disease: A Critical Review of Emerging EvidenceSemantic proximity Read

Early Signs of Gut Microbiome Aging: Biomarkers of Inflammation, Metabolism, and Macromolecular Damage in Young AdulthoodSemantic proximity Read

Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases.Semantic proximity Read

Fecal calprotectin measurement as a biomarker of severe disease phenotype in celiac disease and non-celiac enteropathies.Semantic proximity Read

Identifying Robust Biomarkers for the Diagnosis and Subtype Distinction of Inflammatory Bowel Disease through Comprehensive Serum Metabolomic ProfilingSemantic proximity Read

Age and the aging process significantly alter the small bowel microbiomeSemantic proximity Read

Weighted Gene Co-Expression Network Analysis Identifies a Functional Guild and Metabolite Cluster Mediating the Relationship between Mucosal Inflammation and Adherence to the Mediterranean Diet in Ulcerative ColitisSemantic proximity Read